Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-126262

Clearside Biomedical, Inc. · CLSD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Clay Thorp
Director · 10% Owner
John Crumpler
10% Owner
Period of report
Jun 7, 2016
Accepted (ET)
Jun 7, 2016 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001539029

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Jun 7, 2016C1,598,223—A1,654,248IBy Hatteras Venture Partners IV SBIC, LP
Common StockF3Jun 7, 2016X21,705$0.022A1,675,953IBy Hatteras Venture Partners IV SBIC, LP
Common StockF3Jun 7, 2016S69$7.00D1,675,884IBy Hatteras Venture Partners IV SBIC, LP
Common StockF3Jun 7, 2016P414,286$7.00A2,090,170IBy Hatteras Venture Partners IV SBIC, LP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Preferred StockF3,F2—Jun 7, 2016C2,035,908D——Common Stock925,4120I
Series A-1 Preferred StockF3,F2—Jun 7, 2016C689,388D——Common Stock313,3580I
Series B Preferred StockF3,F2—Jun 7, 2016C432,941D——Common Stock196,7910I
Series C Preferred StockF3,F2—Jun 7, 2016C337,897D——Common Stock162,6620I
Warrant to Purchase Common Stock (right to buy)F3,F5$0.022Jun 7, 2016X21,705DApr 28, 2014—Common Stock21,7050I

Explanation of responses